Iranian general populations' and health care providers' preferences for benefits and harms of statin therapy for primary prevention of cardiovascular disease
Abstract Background The use of statins for primary prevention of cardiovascular diseases is associated with different benefit and harm outcomes. The aime of this study is how important these outcomes are for people and what people's preferences are. Methods We conducted a preference-eliciting s...
Main Authors: | Hassan Saadati, Hamid Reza Baradaran, Goodarz Danaei, Afshin Ostovar, Farzad Hadaegh, Leila Janani, Ewout W. Steyerberg, Davood Khalili |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-11-01
|
Series: | BMC Medical Informatics and Decision Making |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12911-020-01304-w |
Similar Items
-
Should statin guidelines consider patient preferences? Eliciting preferences of benefit and harm outcomes of statins for primary prevention of cardiovascular disease in the sub-Saharan African and European contexts
by: Henock G. Yebyo, et al.
Published: (2018-05-01) -
Global variation of risk thresholds for initiating statins for primary prevention of cardiovascular disease: a benefit-harm balance modelling study
by: Henock G. Yebyo, et al.
Published: (2020-09-01) -
Statin Therapy and Cognitive Impairment: Benefit or Harm?
by: O. D. Ostroumova, et al.
Published: (2018-09-01) -
The burden of statin therapy in urban population of Iran based on new ACC/AHA guideline
by: Samaneh Asgari, et al.
Published: (2015-03-01) -
Fasting: Benefits and probable health harmfulness from the Islamic perspective
by: Mahdi Ebrahimi, et al.
Published: (2015-06-01)